1. Home
  2. MXCT vs SRL Comparison

MXCT vs SRL Comparison

Compare MXCT & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.86

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Logo Scully Royalty Ltd.

SRL

Scully Royalty Ltd.

HOLD

Current Price

$6.95

Market Cap

104.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
SRL
Founded
1999
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
104.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
MXCT
SRL
Price
$0.86
$6.95
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
649.5K
15.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
16.07%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,026,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$5.13
52 Week High
$2.86
$10.39

Technical Indicators

Market Signals
Indicator
MXCT
SRL
Relative Strength Index (RSI) 54.22 44.46
Support Level $0.65 $6.80
Resistance Level $0.89 $7.30
Average True Range (ATR) 0.05 0.25
MACD 0.00 0.04
Stochastic Oscillator 62.88 79.90

Price Performance

Historical Comparison
MXCT
SRL

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: